FOLFIRINOX vs gemcitabine/nab-paclitaxel for treatment of metastatic pancreatic cancer: Single-center cohort study

BACKGROUND: FOLFIRINOX and gemcitabine plus nab-paclitaxel (Gem + nabPTX) were recently introduced for metastatic pancreatic cancer treatment. However, studies that compared these two regimens and studies in Asian populations are lacking. AIM: To compare the treatment outcomes of FOLFIRINOX and Gem...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:World J Gastrointest Oncol
Autori principali: Cho, In Rae, Kang, Huapyong, Jo, Jung Hyun, Lee, Hee Seung, Chung, Moon Jae, Park, Jeong Youp, Park, Seung Woo, Song, Si Young, An, Chansik, Park, Mi-Suk, Bang, Seungmin
Natura: Artigo
Lingua:Inglês
Pubblicazione: Baishideng Publishing Group Inc 2020
Soggetti:
Retrospective Cohort Study
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7031147/
https://ncbi.nlm.nih.gov/pubmed/32104549
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4251/wjgo.v12.i2.182
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi